Related Experiment Video
Updated: Mar 26, 2026

14:19
Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
28.8K
Intrauterine growth restriction - part 1
Deepak Sharma1, Sweta Shastri2, Nazanin Farahbakhsh3
1a Department of Pediatrics , Pt. B.D. Sharma PGIMS , Rohtak , India .
Summary
Intrauterine growth restriction (IUGR) is a significant cause of fetal and neonatal complications. This review covers the antenatal aspects and management of IUGR, focusing on proven preventive interventions for better fetal development.
Area of Science:
- Perinatology
- Fetal Medicine
- Neonatology
Background:
- Intrauterine growth restriction (IUGR) is a critical condition impacting fetal and neonatal health, often leading to significant morbidity and mortality.
- IUGR is characterized by fetal growth falling below its normal potential for a specific infant.
- While often used interchangeably, IUGR and small for gestational age (SGA) have distinct definitions.
Purpose of the Study:
- To provide a comprehensive review of the antenatal aspects of intrauterine growth restriction (IUGR).
- To discuss the various etiologies contributing to IUGR, including maternal, placental, fetal, and genetic factors.
- To highlight proven preventive interventions and management strategies for IUGR during the antenatal period.
Main Methods:
- This is a review article, synthesizing existing literature on IUGR.
- Focuses on antenatal factors and interventions.
- Examines maternal, placental, fetal, and genetic contributions to IUGR.
Main Results:
- IUGR stems from diverse etiologies: maternal, placental, fetal, and genetic factors.
- Antenatal identification and management are crucial for mitigating IUGR's impact.
- Proven preventive strategies exist for managing IUGR.
Conclusions:
- IUGR is a complex condition with multifactorial causes requiring a thorough understanding of antenatal influences.
- Effective antenatal management and preventive interventions are key to improving fetal and neonatal outcomes.
- Distinguishing between IUGR and SGA is important for accurate diagnosis and tailored care.
Related Concept Videos
Intrauterine Drug Delivery Systems
126
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
126
Teratogenicity
4.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K

